SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039770
Filing Date
2022-06-29
Accepted
2022-06-29 15:48:19
Documents
1
Period of Report
2022-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5791
  Complete submission text file 0001209191-22-039770.txt   7155
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Business Address
Sanders Corazon (Corsee) D. (Reporting) CIK: 0001796536 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 221054518